Research output per year
Research output per year
Search results
-
2017
PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC)
Faivre-Finn, C., Kordbacheh, T., Chan, C., Bossons, A., Franks, K., McDonald, F., Forster, M., Mendes, R., Quezada, S., Dovedi, S., Ralph, C., Popat, S., Harrington, K., Melcher, A., Popple, A. & Illidge, T., Jan 2017, p. S75(164).Research output: Contribution to conference › Abstract › peer-review